Clayton Christensen on small market versus blockbuster

Last year, Clayton Christensen, a keynote presenter at the 18th Annual Partnerships with CROs, focused on disruptive innovation in the Pharma industry as he discussed how it is on the precipice of major change where strategic sourcing/partnering approaches that provoke or complement disruptive change could be an important solution. In this portion of his speech, he looks at how blockbuster and small market drugs have changed over the past few decades.

Watch Part 3 of the presentation in the Multimedia box at the bottom of the page under “Video”:


This year, we’re excited to have , Jason Hwang, MD, MBA, Executive Director of Healthcare, Innosight Institute, who was the co-author of The Innovator’s Prescription: A Disruptive Solution for Health Care. He will be presenting the keynote speech, “Value Creation through strategic sourcing and new business Models, “ on Wednesday, April 14 at Partnerships in Clinical Trials. For more information on his presentation and others at Partnerships in Clinical Trials, download the brochure here.

Share this article with your social network, just click below to share now!

Share |